Cresco Labs (CRLBF) Long-Term Deferred Tax (2019 - 2026)

Cresco Labs has reported Long-Term Deferred Tax for 8 years, with the latest figure at $13.6 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Deferred Tax rose 5.58% year-over-year to $13.6 million; the trailing twelve-month figure through Mar 2026 stood at $13.6 million (up 5.58% YoY), and the FY2025 full-year result was $13.5 million, up 2.85% from the prior year.
• Long-Term Deferred Tax for Q1 2026 stood at $13.6 million, up from $13.5 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $17.6 million in Q2 2024, with the low at $26000.0 in Q4 2022.
• Historically, Long-Term Deferred Tax has averaged $10.7 million across 5 years, with a median of $12.4 million in 2025.
• Annual changes were most pronounced in 2022 — Long-Term Deferred Tax tumbled 99.6% — and 2023, when it soared 44311.54%.
• Cresco Labs' Long-Term Deferred Tax stood at $26000.0 in 2022, then soared by 44311.54% to $11.5 million in 2023, then rose by 13.68% to $13.1 million in 2024, then rose by 2.85% to $13.5 million in 2025, then increased by 1.09% to $13.6 million in 2026.
• The last three Long-Term Deferred Tax figures came in at $13.6 million (Q1 2026), $13.5 million (Q4 2025), and $12.4 million (Q3 2025), per Business Quant data.